The peptide shows a great deal of promise not just as therapeutic agent for promoting wound healing and regulating vascular growth, but as a tool for investigating these processes to better understand their control
Important Considerations Individual Variation: L-cell density and function vary significantly between individuals based on genetics, age, gut health history, and metabolic status
In order to participate in the pilot program, you must also fall into one of the three following categories: Have a BMI of 35 or greater Have a BMI between 30 and 35, along with one or more of the following: heart failure, hypertension, chronic kidney disease, prediabetes, a previous heart attack, peripheral artery disease Have a BMI between 27 and 30, along with one or more of the following: prediabetes, a previous heart attack, peripheral artery disease The Medicare website has a page dedicated to the Bridge program, with additional details on the health qualifications
What stopping retatrutide WILL do is eliminate the metabolic benefits you are gaining and potentially lead to weight regain, which creates its own set of hormonal disruptions that can trigger a second wave of shedding